Dr Mary Fidler of Rush University Medical Center, Chicago, IL, and Dr Arturo Loaiza-Bonilla of the Comprehensive Care and Research Center, Philadelphia, PA, describe their practical experiences with TRK inhibitors in patients with lung cancer and colorectal cancer.
Real-World Experience with TRK Inhibitors in Patients with Lung and Colon Cancers
Videos — June 11, 2021
Professor of Medicine
Chief
Division of Hematology/Oncology
UC San Diego
La Jolla, CA
Chief
Division of Hematology/Oncology
UC San Diego
La Jolla, CA
Associate Professor and Section Chief
Medical Oncology
Rush University Medical Center
Chicago, IL
Medical Oncology
Rush University Medical Center
Chicago, IL
Enterprise Medical Director of Research
Comprehensive Care and Research Center
Philadelphia, PA
Comprehensive Care and Research Center
Philadelphia, PA
